国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Francisella tularensis subsp. tularensis Phosphatidylserine decarboxylase proenzyme (psd) CSB-YP614864FAAD
CSB-EP614864FAAD
CSB-BP614864FAAD
CSB-MP614864FAAD
CSB-EP614864FAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. tularensis 50S ribosomal protein L36 (rpmJ) CSB-YP614865FAAD
CSB-EP614865FAAD
CSB-BP614865FAAD
CSB-MP614865FAAD
CSB-EP614865FAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. tularensis 50S ribosomal protein L18 (rplR) CSB-YP614866FAAD
CSB-EP614866FAAD
CSB-BP614866FAAD
CSB-MP614866FAAD
CSB-EP614866FAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. tularensis 30S ribosomal protein S19 (rpsS) CSB-YP614867FAAD
CSB-EP614867FAAD
CSB-BP614867FAAD
CSB-MP614867FAAD
CSB-EP614867FAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. tularensis 30S ribosomal protein S2 (rpsB) CSB-YP614868FAAD
CSB-EP614868FAAD
CSB-BP614868FAAD
CSB-MP614868FAAD
CSB-EP614868FAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. tularensis Adenylosuccinate synthetase (purA) CSB-YP614869FAAD
CSB-EP614869FAAD
CSB-BP614869FAAD
CSB-MP614869FAAD
CSB-EP614869FAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. tularensis Ribosome maturation factor RimM (rimM) CSB-YP614870FAAD
CSB-EP614870FAAD
CSB-BP614870FAAD
CSB-MP614870FAAD
CSB-EP614870FAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. tularensis Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP614871FAAD
CSB-EP614871FAAD
CSB-BP614871FAAD
CSB-MP614871FAAD
CSB-EP614871FAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. tularensis Triosephosphate isomerase (tpiA) CSB-YP614872FAAD
CSB-EP614872FAAD
CSB-BP614872FAAD
CSB-MP614872FAAD
CSB-EP614872FAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. tularensis NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP614873FAAD1
CSB-EP614873FAAD1
CSB-BP614873FAAD1
CSB-MP614873FAAD1
CSB-EP614873FAAD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bone sialoprotein-binding protein (bbp), partial CSB-YP614874FKZ
CSB-EP614874FKZ
CSB-BP614874FKZ
CSB-MP614874FKZ
CSB-EP614874FKZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human 26S proteasome non-ATPase regulatory subunit 6 (PSMD6) CSB-YP614875HU
CSB-EP614875HU
CSB-BP614875HU
CSB-MP614875HU
CSB-EP614875HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Exosome complex component RRP42 (EXOSC7) CSB-YP614876HU
CSB-EP614876HU
CSB-BP614876HU
CSB-MP614876HU
CSB-EP614876HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Sorting nexin-17 (SNX17) CSB-YP614877HU
CSB-EP614877HU
CSB-BP614877HU
CSB-MP614877HU
CSB-EP614877HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL6IP1), partial CSB-YP614878HU1
CSB-EP614878HU1
CSB-BP614878HU1
CSB-MP614878HU1
CSB-EP614878HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Ribosome biogenesis regulatory protein homolog (RRS1) CSB-YP614879HU
CSB-EP614879HU
CSB-BP614879HU
CSB-MP614879HU
CSB-EP614879HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human WD repeat-containing protein 43 (WDR43) CSB-YP614880HU
CSB-EP614880HU
CSB-BP614880HU
CSB-MP614880HU
CSB-EP614880HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Procollagen C-endopeptidase enhancer 1 (PCOLCE) CSB-YP614881HU
CSB-EP614881HU
CSB-BP614881HU
CSB-MP614881HU
CSB-EP614881HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (PLCB4), partial CSB-YP614882HU
CSB-EP614882HU
CSB-BP614882HU
CSB-MP614882HU
CSB-EP614882HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Serum paraoxonase/lactonase 3 (PON3) CSB-YP614883HU
CSB-EP614883HU
CSB-BP614883HU
CSB-MP614883HU
CSB-EP614883HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>